ONTOZRY instauration traite 14x12.5,14x25mg 28 pce
7680680510117
CH-68051
N03AX25
01.07.1.
Reimbursement limitations:
ONTOZRY.01
Ontozry est indiqué chez l'adulte atteint d'une épilepsie non contrôlée par au moins deux traitements …
1 / 3
google
Details
- Product number
- 6805107
- CPT
- -
- Packaging group
- 2x 14
- Unit
- Tablette(n)
- Composition
- I) Ontozry 12.5 mg, Tablette: cenobamatum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 39.67 mg, carboxymethylamylum natricum A corresp. natrium 0.16 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. II) Ontozry 25 mg, Filmtablette: cenobamatum 25 mg, cellulosum microcristallinum, lactosum monohydricum 79.34 mg, carboxymethylamylum natricum A corresp. natrium 0.32 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum, talcum, E 172 (flavum), E 172 (rubrum), E 132, pro compresso obducto.
Articles (1)
Ontozry 12.5 mg, Tabletten und Ontozry 25 mg, Filmtabletten
Filmtabletten
2x 14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
39.67 MG | Substance | HBESI |
|
II
|
79.34 MG | Substance | HBESI |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
0.16 MG | Substance | HBESI |
|
II
|
0.32 MG | Substance | HBESI |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | FNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | FTODK |
|
II
|
- | Substance | FTODK |
|
II
|
- | Substance | FIMDK |
Reimbursement information
Public price
CHF 117.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2022
Authorization holder
Angelini Pharma S.p.A., Rom,
6301 Zug
Authorization information
- Swissmedic authorization number
- 68051
- Drug name
- Ontozry, Filmtabletten + Tabletten
- Galenic form
- FITT
- ATC Code
- N03AX25
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/05/2022
- Authorization expiration date
- 18/05/2027
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONTOZRY instauration traite 14x12.5,14x25mg 28 pce
- Description (DE)
- ONTOZRY Starterpackung 14x12.5,14x25mg 28 Stk
- Market launch
- 19/05/2022
- Narcotic (BTM)
- No